Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

NCT07189871

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
Locations: Dothan Hematology & Oncology Dothan, Alabama, United States

BAMF Health Grand Rapids, Michigan, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

XCancer Omaha, Nebraska, United States

View Trial Details

Recruiting

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

NCT06687941

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +21 more
Locations: National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea

CHA Bundang Medical Center Seongnam, South Korea

Severance Hospital Seoul, South Korea

Samsung Medical Center Seoul, South Korea

View Trial Details

Recruiting

A Retrospective Real-World Study Based on RATIONALE-307

NCT07478809

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients

NCT07138755

Conditions: Adaptive Radiotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Xiangya 3rd Hospital, Central South University Changsha, Hunan, China

View Trial Details

Recruiting

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

NCT05024214

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations: The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China

The Seventh Medical Center of the PLA General Hospital Beijing, Beijing Municipality, China

Beijing Hospital Beijing, Beijing Municipality, China

Fujian Medical University Union Hospital Fuzhou, Fujian, China

View all 23 locations

View Trial Details

Recruiting

Phase III Study of Envafolimab Versus Placebo Plus Chemotherapy in Resectable Stage III NSCLC

NCT06123754

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Tianjin cancer hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

NCT05805631

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Department of Chest Medicine, Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Recruiting

Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC

NCT05669846

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

NCT07218601

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations

NCT07336732

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, China

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions